Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 1, 2021

View Archived Issues

Recombinant hemagglutinin-expressing HSV vector offers protection against both HSV and influenza

Compound inhibits acute myeloid leukemia cells with FLT3-ITD mutations by targeting HSP70

Aston University descibres new antibacterials

New antivirals presented by EcoSynth, Transmare Chemie

Leiden University and collaborators patent monoglyceride lipase inhibitors

PTGER4 antagonists discovered at Hubei Bio-Pharmaceutical, Humanwell Healthcare

APMAP identified as a regulator of cancer cell phagocytosis

Kynurenine metabolites as biomarkers of chronic fatigue syndrome and fibromyalgia

Primate model of autism spectrum disorder reveals potential therapeutic targets

Identification of novel viral cleavage sites and potential therapeutic targets against SARS-CoV-2

Antibodies targeting glycosylated CD44 synthesized at Go Therapeutics

Different way of looking allows new insights into cancer biology

Elastase inhibition enhances the adjuvant activity of alum for SARS-CoV-2 vaccination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...